nfr-logonfr-logo
PROJECT BANK
Switch to English
Statistics
Projects

0 projects

Date from new to old

H20-HEALTH-Health, demographic change and wellbeing

BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

Awarded: NOK 10.6 mill.

Project Period: 2021-2026

Location: Oslo og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Innovations to accelerate vaccine development and manufacture

Innovations to accelerate vaccine development and manufacture

Awarded: NOK 16.5 mill.

Project Period: 2021-2027

Location: Oslo og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials

Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials

Awarded: NOK 3.4 mill.

Project Period: 2021-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment

Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment

Awarded: NOK 32.1 mill.

Project Period: 2020-2025

Location: Oslo og 3 andre

H20-HEALTH-Health, demographic change and wellbeing

Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

Awarded: NOK 0.63 mill.

Project Period: 2020-2023

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

Awarded: NOK 1.2 mill.

Project Period: 2019-2025

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

Awarded: NOK 2.3 mill.

Project Period: 2019-2025

Location: Rogaland

H20-HEALTH-Health, demographic change and wellbeing

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

Awarded: NOK 2.0 mill.

Project Period: 2019-2026

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug

Parkinson Disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease. There is an unmet clinical need to treat Parkinson disease with mild cognitive impairment (PD-MCI). There is ample evidence from epidemiological studies as well as (pre)clinical research that Nic...

Awarded: NOK 0.30 mill.

Project Period: 2019-2022

Location: Oslo og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement

Awarded: NOK 20.2 mill.

Project Period: 2019-2024

Location: Trøndelag - Trööndelage

H20-HEALTH-Health, demographic change and wellbeing

Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation

Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation

Awarded: NOK 7.0 mill.

Project Period: 2019-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Vaccines and Infectious Diseases in the Ageing PopuLation

Vaccines and Infectious Diseases in the Ageing PopuLation

Awarded: NOK 3.3 mill.

Project Period: 2019-2023

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients

Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease (AID) involving 0.5 to 3/1000 persons. The disease affects exocrine glands leading to dryness of the eyes and the mouth and is associated with fatigue and limb pain. In 30% to 50% of the patients, systemic and extra-glandular manif...

Awarded: NOK 1.0 mill.

Project Period: 2019-2024

Location: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Bringing a prophylactic Ebola vaccine to licensure

Bringing a prophylactic Ebola vaccine to licensure

Awarded: Hidden

Project Period: 2018-2023

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

conect4children (COllaborative Network for European Clinical Trials For Children)

conect4children (COllaborative Network for European Clinical Trials For Children)

Awarded: NOK 6.5 mill.

Project Period: 2018-2024

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797

Preclinical type 1 diabetes (T1D) research has made important advances in recent years, but less progress has been made in translating findings from in vitro and animal models into effective clinical interventions. INNODIA aims to achieve a breakthrough in the way in which we study T1D to enable ...

Awarded: NOK 3.5 mill.

Project Period: 2015-2022

Location: Oslo

1